Cancer Research Career Enhancement and Related Activities

癌症研究职业提升及相关活动

基本信息

项目摘要

PROJECT SUMMARY: CANCER RESEARCH CAREER ENHANCEMENT As the only academic Cancer Center in its four-county catchment area (South Florida), the Sylvester Comprehensive Cancer Center (Sylvester) has a unique responsibility to provide cancer-focused education and training across the career continuum. Sylvester’s Office of Education and Training (OET) coordinates these activities, ensuring they meet and exceed the needs of diverse learners, including students, pre- and postdoctoral trainees, faculty, and healthcare professionals. Kerry L. Burnstein, PhD, Associate Director for Education and Training leads the OET, overseeing the strategic development, coordination, and evaluation of these efforts with assistance from Sylvester leadership and administration, Sylvester’s External Advisory Board, and the Cancer Education Leadership Council, an internal advisory committee comprising University leaders in education, training, and mentoring. They work together to achieve the career enhancement priorities identified in Sylvester’s 2014-2018 Strategic Plan to 1) Build and sustain cancer research careers through stage-specific scientific and professional development; and 2) Provide broad, crosscutting career enhancement and educational programs that facilitate collaborative, interdisciplinary cancer research. While many of the Center’s education and training activities are new, for the past 12 years the Cancer Biology Graduate (CAB) Program has successfully educated dozens of promising graduate students in basic or translational cancer research. Sylvester trainees have been productive and engaged in impactful cancer research; of the 150 publications highlighted by Sylvester’s three Research Programs, trainees were first or second author on 50%. Recently, Sylvester members received five cancer-focused or related T32 training grants, an international U54 grant with Argentina that has a significant education and training component, and an NCI K12 Calabresi award, which will begin enrolling physician scientists in 2019. To extend the impact of these grants, Sylvester will fund an additional trainee for the T32s awards and the K12. Sylvester supports traditional career enhancement activities such as distinguished lecture series, annual retreats, trainee speaking opportunities, and novel educational strategies including a nurse practitioner oncology fellowship and opportunities for medical students to work in medically underserved communities with cancer control experts. Given the unparalleled multicultural and linguistic diversity of the catchment area, Burnstein and the OET work with the University of Miami Clinical and Translational Science Institute leadership and Sylvester’s Associate Director for Population Science and Cancer Disparity to ensure that trainees receive didactic and experiential instruction on how cancer risk and outcome vary across populations, allowing them to consider and possibly incorporate this knowledge into their research design. Together these efforts foster a pipeline of highly motivated healthcare professionals and researchers, uniquely trained to solve the complex cancer-related problems in their communities and beyond.
项目总结:癌症研究职业提升 作为其四个县集水区(南佛罗里达)唯一的学术癌症中心,西尔维斯特 综合癌症中心(西尔维斯特)有一个独特的责任,提供癌症为重点的教育 和职业生涯中的培训。西尔维斯特的教育和培训办公室(OET)协调 这些活动,确保他们满足和超越不同的学习者,包括学生,学前和 博士后学员、教师和医疗保健专业人员。克里湖Burnstein博士,副主任, 教育和培训领导OET,监督战略发展,协调和评估 这些努力得到了西尔维斯特领导层和行政部门、西尔维斯特的外部顾问 董事会和癌症教育领导理事会,一个内部咨询委员会,包括大学 教育、培训和指导方面的领导者。他们共同努力实现职业发展的优先事项 在西尔维斯特的2014-2018年战略计划确定1)建立和维持癌症研究事业,通过 特定阶段的科学和专业发展; 2)提供广泛的,跨领域的职业发展 和教育计划,促进合作,跨学科的癌症研究。虽然许多 中心的教育和培训活动是新的,过去12年的癌症生物学研究生(CAB) 该计划已成功地教育了数十名有前途的研究生在基础或转化癌症 research.西尔维斯特的受训人员富有成效,并从事有影响力的癌症研究;在150名 在西尔维斯特的三个研究项目所强调的出版物中,学员是50%的第一或第二作者。 最近,西尔维斯特成员收到了五个癌症重点或相关的T32培训赠款,一个国际U 54 与阿根廷的赠款,有一个重要的教育和培训组成部分,和一个NCI K12卡拉布雷西奖, 将于2019年开始招收内科科学家。为了扩大这些赠款的影响,西尔维斯特将资助 T32和K12的额外学员。西尔维斯特支持传统的职业提升 活动,如杰出的讲座系列,年度务虚会,实习生发言的机会,和小说 教育战略,包括执业护士肿瘤学奖学金和医科学生的机会 与癌症控制专家一起在医疗服务不足的社区工作。鉴于无与伦比的多元文化 和语言多样性的集水区,伯恩斯坦和OET与迈阿密大学临床 和转化科学研究所的领导和西尔维斯特的人口科学副主任, 癌症差异,以确保受训者接受教学和经验指导,如何癌症的风险和 结果因人群而异,使他们能够考虑并可能将这些知识纳入他们的 研究设计这些努力共同培养了一批积极进取的医疗保健专业人员, 研究人员,经过独特的培训,以解决他们社区内外的复杂癌症相关问题。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kerry L Burnstein其他文献

Kerry L Burnstein的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kerry L Burnstein', 18)}}的其他基金

Covid-19: Fast-tracking treatment by exploiting the steroid hormone receptor/TMPRSS2 axis
Covid-19:利用类固醇激素受体/TMPRSS2 轴进行快速治疗
  • 批准号:
    10814125
  • 财政年份:
    2021
  • 资助金额:
    $ 4.69万
  • 项目类别:
Covid-19: Fast-tracking treatment by exploiting the steroid hormone receptor/TMPRSS2 axis
Covid-19:利用类固醇激素受体/TMPRSS2 轴进行快速治疗
  • 批准号:
    10153099
  • 财政年份:
    2021
  • 资助金额:
    $ 4.69万
  • 项目类别:
Covid-19: Fast-tracking treatment by exploiting the steroid hormone receptor/TMPRSS2 axis
Covid-19:利用类固醇激素受体/TMPRSS2 轴进行快速治疗
  • 批准号:
    10341159
  • 财政年份:
    2021
  • 资助金额:
    $ 4.69万
  • 项目类别:
Cancer Research Career Enhancement and Related Activities
癌症研究职业提升及相关活动
  • 批准号:
    10190856
  • 财政年份:
    2019
  • 资助金额:
    $ 4.69万
  • 项目类别:
Cancer Research Career Enhancement and Related Activities
癌症研究职业提升及相关活动
  • 批准号:
    10443633
  • 财政年份:
    2019
  • 资助金额:
    $ 4.69万
  • 项目类别:
Cancer Research Career Enhancement and Related Activities
癌症研究职业提升及相关活动
  • 批准号:
    10670835
  • 财政年份:
    2019
  • 资助金额:
    $ 4.69万
  • 项目类别:
A Novel Drug Target for Aggressive Prostate Cancer
侵袭性前列腺癌的新药物靶点
  • 批准号:
    10083680
  • 财政年份:
    2018
  • 资助金额:
    $ 4.69万
  • 项目类别:
Vav3 Oncogene Potentiation of Androgen Receptor Signaling in Prostate Cancer.
Vav3 致癌基因对前列腺癌中雄激素受体信号传导的增强作用。
  • 批准号:
    8056479
  • 财政年份:
    2009
  • 资助金额:
    $ 4.69万
  • 项目类别:
Vav3 Oncogene Potentiation of Androgen Receptor Signaling in Prostate Cancer.
Vav3 致癌基因对前列腺癌中雄激素受体信号传导的增强作用。
  • 批准号:
    8459533
  • 财政年份:
    2009
  • 资助金额:
    $ 4.69万
  • 项目类别:
Vav3 Oncogene Potentiation of Androgen Receptor Signaling in Prostate Cancer.
Vav3 致癌基因对前列腺癌中雄激素受体信号传导的增强作用。
  • 批准号:
    8257572
  • 财政年份:
    2009
  • 资助金额:
    $ 4.69万
  • 项目类别:

相似海外基金

Advisory Committees
咨询委员会
  • 批准号:
    7353899
  • 财政年份:
    2006
  • 资助金额:
    $ 4.69万
  • 项目类别:
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
  • 批准号:
    0451289
  • 财政年份:
    2005
  • 资助金额:
    $ 4.69万
  • 项目类别:
    Standard Grant
Advisory Committees
咨询委员会
  • 批准号:
    7557224
  • 财政年份:
  • 资助金额:
    $ 4.69万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7902286
  • 财政年份:
  • 资助金额:
    $ 4.69万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7691385
  • 财政年份:
  • 资助金额:
    $ 4.69万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    8150373
  • 财政年份:
  • 资助金额:
    $ 4.69万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了